Newsletter
Clinical Trial Update
News filed under Clinical Trial Update, newest first.
Showing 6–10 of 10 stories
Top story
Ascletis Reports Positive Phase I Results for ASC50 in Plaque Psoriasis
Oral IL-17A Inhibitor Shows Positive Results in 28-Day Proof-of-Concept Study Ascletis Pharma Inc...
Read story
AI in Clinical Trials Market to Reach USD 7.32 Billion by 2034
Market Expected to Grow at 15.5% CAGR From 2026 to 2034 The global AI in Clinical Trials Market i...
Read story
Kodiak Sciences to Report Phase 3 DAYBREAK Results for Zenkuda and KSI-501
Topline Results Will Evaluate Treatments for Wet Age-Related Macular Degeneration Kodiak Sciences...
Read story
Gossamer Bio submits NDA to US FDA for seralutinib to treat pulmonary arterial hypertension
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on the development and commer...
Read story
Newron Provides Update on Phase 3 ENIGMA-TRS 2 Study
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical co...
Read storyPage 2 of 2
